MKMehdi Khaleghi

Mehdi Khaleghi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mehdi Khaleghi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of endoscope-assisted septectomy and membranectomy for complex chronic subdural hematomas: safety, efficacy, technical feasibility. Patient series

    by Mehdi Khaleghi, Adnan Hussain Shahid, Osama Elkadi, Sudhir Suggala, Garrett Dyes, Asa Record Barnett, Danner Butler, Ursula Noelle Hummel, Jai Deep Thakur

    BACKGROUND: Burr hole craniostomy and conventional craniotomy are respectively associated with high recurrence rates and morbidities in the evacuation of septated chronic subdural hematomas (CSDHs). The safety and efficacy of endoscope-assisted septectomy and membranectomy (ESM) via a mini-craniotomy are investigated in this subset of patients. OBSERVATIONS: Thirteen patients with a mean age of 75 ± 11.5 years and a median modified Rankin Scale (mRS) score of 4 were included. Surgeries had a mean craniotomy size of 3.6 ± 0.5 cm and a median duration of 142 minutes. Initial postoperative CT imaging confirmed complete hematoma evacuation. Six patients (46.2%) underwent perioperative middle meningeal artery embolization (MMAE) without complications. The mean length of hospital stay (LOS) was 8 ± 3.9 days. Lower preoperative Glasgow Coma Scale (GCS) scores (p = 0.049) and larger midline shifts (p = 0.024) were significantly associated with LOS > 5 days. Median mRS scores significantly improved at discharge (p < 0.015) and at the last follow-up (p < 0.009), yielding a low-tier mRS score (≤ 2) in 53.8% of patients at discharge and 92.3% favorable last follow-up outcomes. A higher admission GCS score was associated with a low-tier at-discharge mRS score (p = 0.048). Complete brain reexpansion occurred within a mean time of 6.2 ± 4.1 months, with no significant correlation with radiological and operative features or MMAE history. During a mean follow-up of 17.4 ± 13.4 months, no recurrences were observed. LESSONS: ESM is an effective, minimally invasive alternative for treating septated, multiloculated CSDH, offering minimal recurrences. Although operative times are longer, reduced reoperation rates and improved safety justify this strategy for complex hematomas. https://thejns.org/doi/10.3171/CASE25446

    • 23 March 2026
      • Vol. 11  (12)
    Open Access

    The role of endoscope-assisted septectomy and membranectomy for complex chronic subdural hematomas: safety, efficacy, technical feasibility. Patient series

    by Mehdi Khaleghi, Adnan Hussain Shahid, Osama Elkadi, Sudhir Suggala, Garrett Dyes, Asa Record Barnett, Danner Butler, Ursula Noelle Hummel, Jai Deep Thakur

    Burr hole craniostomy and conventional craniotomy are respectively associated with high recurrence rates and morbidities in the evacuation of septated chronic subdural hematomas (CSDHs). The safety and efficacy of endoscope-assisted septectomy and membranectomy (ESM) via a mini-craniotomy are investigated in this subset of patients. Thirteen patients with a mean age of 75 ± 11.5 years and a median modified Rankin Scale (mRS) score of 4 were included. Surgeries had a mean craniotomy size of 3.6 ± 0.5 cm and a median duration of 142 minutes. Initial postoperative CT imaging confirmed complete hematoma evacuation. Six patients (46.2%) underwent perioperative middle meningeal artery embolization (MMAE) without complications. The mean length of hospital stay (LOS) was 8 ± 3.9 days. Lower preoperative Glasgow Coma Scale (GCS) scores (p = 0.049) and larger midline shifts (p = 0.024) were significantly associated with LOS > 5 days. Median mRS scores significantly improved at discharge (p < 0.015) and at the last follow-up (p < 0.009), yielding a low-tier mRS score (≤ 2) in 53.8% of patients at discharge and 92.3% favorable last follow-up outcomes. A higher admission GCS score was associated with a low-tier at-discharge mRS score (p = 0.048). Complete brain reexpansion occurred within a mean time of 6.2 ± 4.1 months, with no significant correlation with radiological and operative features or MMAE history. During a mean follow-up of 17.4 ± 13.4 months, no recurrences were observed. ESM is an effective, minimally invasive alternative for treating septated, multiloculated CSDH, offering minimal recurrences. Although operative times are longer, reduced reoperation rates and improved safety justify this strategy for complex hematomas. https://thejns.org/doi/10.3171/CASE25446

  • Endoscopic Supraorbital Translaminar Approach

    by Mehdi Khaleghi, Kyle C. Wu, Daniel M. Prevedello

    Surgical selection for third ventricle tumors demands meticulous planning, given the complex anatomic milieu. Traditional open microsurgical approaches may be limited in their access to certain tumors, prompting the exploration of alternative techniques. The endoscopic supraorbital translaminar approach (ESOTLA) has emerged as a promising alternative for managing these tumors. By combining a minimally invasive keyhole approach with endoscopic visualization, the ESOTLA provides enhanced illumination and a wider angle of view within the third ventricle. This unique advantage allows for improved access to retrochiasmatic tumors and reduces the need for frontal lobe and optic chiasm retraction required of microscopic techniques, decreasing the risk of neurocognitive and visual deficits. Complications related to the ESOTLA are rare and primarily pertain to cosmetic issues and potential compromise of the hypothalamus or optic apparatus, which can be minimized through careful subarachnoid dissection. This chapter offers a comprehensive description of the technical aspects of the ESOTLA, providing insights into its application, advantages, and potential limitations. Additionally, a case description highlights the successful surgical extirpation of an intraventricular papillary craniopharyngioma via the ESOTLA followed by targeted therapy. To better illustrate the stepwise dissection through this novel approach, a series of cadaveric and intraoperative photographs are included.

  • Modified Function-Preserving Endoscopic Endonasal Extracapsular Resection of a Large Orbital Apex Cavernous Hemangioma

    by Mehdi Khaleghi, Lucas P. Carlstrom, Claudio Andres Callejas, Peter Kobalka, Ricardo Carrau, Daniel M. Prevedello

    BACKGROUND AND IMPORTANCE: Various invasive oculoplastic procedures are commonly utilized to control the rectus muscles and widen the surgical corridor through the endoscopic endonasal removal of large orbital apex cavernous hemangiomas (OACHs). They require additional transconjunctival incision, rectus muscle insertional retraction, or muscle deinsertion at the globe that might not be safe and lead to prolonged postoperative extraocular muscle dysfunction. In this article, the authors described a modified 3-handed extracapsular technique for the resection of a large OACH without an additional procedure for rectus muscle control. The aim is to achieve a safe gross total tumor removal while minimizing the procedure-related complications. An intraoperative video is included, along with a stepwise cadaveric dissection relevant to the approach. CLINICAL PRESENTATION: A 71-year-old female presented with progressive left-sided blurred vision, binocular diplopia, and mild proptosis. Contrast-enhanced brain MRI revealed a large heterogeneous enhanced inferomedial intraconal mass in the left orbital apex, mostly consistent with cavernous hemangioma. Gross total tumor removal was achieved through a modified 3-handed endoscopic endonasal extracapsular approach. The diplopia was resolved, and significant visual improvement was achieved. Computed tomography scan demonstrated complete tumor removal, and histological examination confirmed the diagnosis. CONCLUSION: Endoscopic endonasal resection of large OACH can be feasibly performed by using a modified 3-handed extracapsular technique through the generous use of Q-tip swab applicators within the natural separation plane around the tumor capsule and a sequential traction-countertraction method. Subsequently, a gross total removal and optimal postoperative functional outcome are attainable through minimal rectus muscle fiber violation and intraconal fat manipulation.


  • Successful treatment of medically and surgically refractory lymphocytic hypophysitis with fractionated stereotactic radiotherapy: a single-center experience and systematic literature review

    by Mehdi Khaleghi, Guilherme Finger, Kyle C. Wu, Vikas Munjal, Luma Ghalib, Peter Kobalka, Dukagjin Blakaj, Khaled Dibs, Ricardo Carrau, Daniel Prevedello

    Purpose To explore the potential role of focused radiotherapy in managing the lymphocytic hypophysitis (LH) refractory to medical therapy and surgery. Method A systematic literature review was conducted following PRISMA guidelines to identify the studies on radiation treatment for hypophysitis, along with the experience in our institution. Results The study included eight patients, three from our institution and five from existing literature. The age at presentation ranged from 37 to 75 years old, with a median age of 58. The presenting symptoms involved headache in seven patients and diplopia in two patients. Pre-radiation visual field defects were noticed in four patients. All patients exhibited variable degrees of hypopituitarism before radiation, with oral corticosteroids being the initial medical treatment. Immunosuppressive therapy was attempted in two patients prior to radiation. Seven patients had a history of transsphenoidal surgery with a histologically confirmed LH. Three patients underwent stereotactic radiosurgery (SRS), while the remaining received FSRT, with a mean irradiation volume of 2.2 cm3. A single-session total dose of 12 -15 Gy was administered in the SRS group. In the FSRT group, doses ranged from 24 to 30 Gy with a median dose of 25 Gy, delivered in 2 Gy fractions. Four patients achieved a resolution of visual field defects, while another two patients demonstrated improvement in their associated focal neurologic deficits. No change in pre-existing endocrine status was shown after radiation, except in one patient. Clinical response was achieved in seven patients after a single course of radiation, while one patient required the second course. Six patients remained stable on low-dose glucocorticoid during at least a 12-month follow-up period, and one discontinued it entirely without experiencing relapse. Three patients demonstrated a complete radiologic response, while the remaining showed a partial radiologic response. Conclusions Focused radiation, including FSRT, can play a role in symptomatic relief, effective mass shrinkage, and minimizing radiation exposure to critical surrounding structures in patients with refractory LH. However, further research efforts are necessary to better clarify its effects and optimal dose planning.